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11th Tuscany Retreat on Cancer Research and
Apoptosis: Genetic proﬁling, resistance
mechanisms and novel treatment concepts in
cancer and neurodegeneration
Justin Pogmore1,2, Joseph Longo 3,4, Diana Resetca3,4, Negin Farivar5,6, Niall A. Buckley7, María G. Rincón8,9,10,
Christina M. Bebber11,12,13, Anusha Venkatraman8,9,10 and James M. Pemberton1,4
For the 11th time, an international assembly of scien-
tists gathered in the medieval castle of Palazzo di Piero,
near the town of Chiusi, Italy, to exchange ideas and
present their research. The opening presentation was
given by Brent Derry (SickKids, Canada), who showed
that alternative polyadenylation regulates oncogenic Ras
in both C. elegans and human cancer cells. His student,
Matthew Eroglu, showcased that genes mstr-1 and mstr-2
are essential for cells to make proper fate decisions. Guy
Taichman, student of Oded Rechavi (Tel Aviv University,
Israel), showed that stress causes a resetting of heritable
RNAi in C. elegans.
Ivano Amelio (University of Cambridge, UK) identiﬁed
that mutant p53 interacts with HIF1α and alters chro-
matin accessibility/architecture. Emanuele Panatta of the
Melino group generated a p73 C-terminal domain mutant
mouse demonstrating that this region is necessary for
proper neurological developmental. Niall Buckley, student
of Dr. Melino, showed that p73 has important function in
the development of epithelial cell cilia, while María Rin-
cón, student of Christoph Borner, reported that lung
epithelial cells treated with Gliotoxin and GSK-3 inhibi-
tors display inhibited caspase-3 activation and high LDH
release.
Silvia von Karstedt (University of Cologne, Germany)
showed that ferroptosis may represent a means of
selection in human cancers. Dr. von Karstedt’s students
then followed; Christina Bebber highlighted that respon-
siveness to ferroptosis is dependent on ASCL-1. Fabienne
Müller showcased MEFs models harboring different
KRAS point mutations exhibit differential ferroptosis
sensitivities. Moreover, Laura Prieto-Clemente demon-
strated a novel role of mitochondria in regulating
ferroptosis.
Revuen Stein (Tel Aviv University, Israel) proposed to
target CAFs in glioma by using an inhibitor of CD38. His
students, Or Ganon and Kaveri Banerjee, presented data
to suggest an unusual distribution of microglia and
macrophages in a mouse model of glioma. Barak Rotblat
(Ben-Gurion University of the Negev, Israel) presented his
research on newly identiﬁed cancer cell vulnerabilities
under glucose starvation. His student, Tal Levy, demon-
strated that glioblastoma cells under glucose starvation
highly depend on 4EBP1, a repressor of protein
translation.
Ronit Pinkas-Kramarski (Tel Aviv University, Israel)
and her student Rawan Bassal presented their research on
the role of autophagy in Alzheimer’s disease and neuro-
degeneration. Other trainees in the Pinkas-Kramarski
group (Hanan Abu Taha, Eya Wolfson, and Adva
Kochavi) showcased their work on the ErbB family of
receptors in cancer, with a focus on disrupting the
crosstalk between ErbB, Ras and Nucleolin with small
molecule inhibitors.
Hartmut Juhl (Indivumed, Germany), introduced the
Indivutype platform, which combines genomic, tran-
scriptomic, microRNA and proteomic datasets from high-
quality cancer biospecimens. John Babcook (Zymeworks,
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Canada) introduced the novel Azymetric™ platform for
the development of IgG-like bispeciﬁc antibodies for the
targeting of synergistic drug targets.
Gerry Melino (University of Cambridge, UK) showcased
the dynamic modulation of expression of the ZNF281 zinc
ﬁnger protein at the DNA damage site during genotoxic
stress. Massimiliano Agostini (University of Tor Vergata,
Italy) presented the role of the transcription factor
ZNF750 in terminal differentiation of the epidermis. His
student, Consuelo Pitolli, presented on the role of the
transcription factor ZNF281 in neuroblastoma. Lukas
Peintner presented his work on the regulation of DNA
damage response in monogenic polycystic kidney disease,
proving that loss of polycystin-1 severely impacts Bcl2
family regulation and DNA repair.
Anne Hamacher-Brady (Johns Hopkins University,
USA) described that during BAX-mediated MOMP,
mitochondria are targeted by endolysosomal vesicles, and
that these inter-organelle interactions are fundamental to
BAX pore formation in cells. Liora Lindenboim demon-
strated that Bax interacts with the nuclear cytoskeleton
via interaction with Nesprin proteins and the LINC
complex. David Andrews (Sunnybrook Research Institute,
Canada) explained how AI analysis of microscopy data
can be used to evaluate apoptosis and other cell responses,
emphasizing potential utility in precision medicine. His
student, Justin Pogmore, presented his work on pharma-
cologically targeting Bax, while James Pemberton sug-
gested that the mechanism of Puma could explain how
neurons commit to either death or axon degeneration.
Christoph Borner (University of Freiburg, Germany),
showcased a novel interaction between Hexokinase-1
and Puma.
Linda Penn (University Health Network, Canada) and
her student Diana Resetca presented the use of MYC-
BioID technology for the identiﬁcation of actionable
protein-protein interactions of the MYC family of onco-
proteins. Joseph Longo, student of Dr. Penn, demon-
strated how the statin family of cholesterol-lowering
drugs could be used to induce apoptosis in a speciﬁc
subset of high-risk multiple myeloma.
Mads Daugaard (Vancouver Prostate Centre, Canada)
showed that cisplatin-resistance in bladder cancer can be
dissected via genome-wide CRISPR screening and tar-
geted by VAR2-drug conjugates. Chris Kedong Wang
showed that cancer exosomes contain high levels of
chondroitin sulfate proteoglycan. Nastaran Khazamipour
discussed the progress toward SPY CAR-T cell engi-
neering for elimination of tumor cells, while Negin Farivar
reported on engineering a plasmonic photothermal ther-
apy to ‘zap’ tumor cells in the blood circulation using gold
nanorods. Nader Al-Nakouzi spoke about the investiga-
tion of hormone-dependent regulation of glycosami-
noglycan signaling in prostate cancer.
Ulrich Maurer (University of Freiburg, Germany)
reported effects of SPATA2 knockout on immune cells in
mice. His student, Laura Griewahn, elucidated the role of
SPATA2 in intestinal cells. Mads Gyrd-Hansen (Uni-
versity of Oxford, UK) showed how SPATA2 facilitates
CYLD recruitment to TNFR. Thomas Brunner (University
of Konstanz, Germany) showed that colorectal tumors can
synthesize and release immunosuppressive glucocorti-
coids, suppressing the anti-tumor immune response.
Michael Bergmann (Medical University of Vienna, Aus-
tria) presented data indicating that radiotherapy polarizes
tumor-associated macrophages from the M2 towards an
M1-like phenotype. Johannes Längle (Bergmann group)
found an impact of proteins associated with DNA
damage, ER stress response, immunogenic cell death and
stress granules on overall survival in liver metastases.
Sebastian Carotta (Boehringer Ingelheim, Vienna) pre-
sented the mechanism of the STING pathway in reg-
ulating immune and cancer cell death. Molecular
oncology work presented by Mahvash Tavassoli (King’s
College, UK) focused on EGFR dynamics and radio-
therapy response in head and neck cancer, and its pro-
pagation by HPV infection. Anusha Venkatraman,
Student of Christoph Borner, showcased a novel virally-
encoded miRNA rendering cells resistant to genotoxic
stress-induced apoptosis. Maria Sibilia (Medical Uni-
versity of Vienna, Austria) indicated that targeting EGFR
on non-cancerous cells in the tumor microenvironment
results in reduced cancer development.
Erwin Wagner (Medical University Vienna, Austria)
showed how the dimeric transcription factor AP-1 plays a
role in inﬂammatory skin disease such as psoriasis, atopic
dermatitis, and inﬂammation-associated liver cancer. John
Silke (WEHI, Australia) showcased mutations that pre-
vent cleavage of RIPK1 by Caspase-8 induce inﬂammation
in humans and mice.
Rudolf Oehler and his student Vanessa Schimek
(Medical University of Vienna, Austria) described the
clearance of apoptotic cells by neutrophils and its
potential role in tissue regeneration. Lukas Kenner
(Medical University of Vienna, Austria) talked about the
role of PDGFRB in anaplastic large cell lymphoma. His
student, Tobias Suske, showed that a hotspot gain-of-
function mutation in Stat5B occurs in patients with
aggressive T cell neoplasia. Karin Nowikovsky (Medical
University of Vienna, Austria) investigated the off-target
effects of a fatty acid synthase inhibitor in a breast cancer
mouse model, identifying a novel synthetic lethality.
Julijan Kabiljo, Bergmann group, showed that antibody-
dependent phagocytosis induced by trastuzumab could be
enhanced by HDAC inhibitors in ex vivo cultures. Balazs
Hegedus (University of Duisburg-Essen, Germany)
demonstrated how pleural effusions from patients with
thoracic malignancies are a source of novel biomarkers to
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yield new preclinical models to study development of
resistance against targeted therapies.
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